Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022;22(30):2527-2533.
doi: 10.2174/1568026622666220512150625.

Radiopharmacokinetics of Graphene Quantum Dots Nanoparticles In vivo: Comparing the Pharmacokinetics Parameters in Long and Short Periods

Affiliations

Radiopharmacokinetics of Graphene Quantum Dots Nanoparticles In vivo: Comparing the Pharmacokinetics Parameters in Long and Short Periods

Matheus Keuper Bastos et al. Curr Top Med Chem. 2022.

Abstract

Background: Nanoparticles (NPs) have gained great importance during the last decades for developing new therapeutics with improved outcomes for biomedical applications due to their nanoscale size, surface properties, loading capacity, controlled drug release, and distribution. Among the carbon-based nanomaterials, one of the most biocompatible forms of graphene is graphene quantum dots (GQDs). GQDs are obtained by converting 2D graphene into zero-dimensional graphene nanosheets. Moreover, very few reports in the literature reported the pharmacokinetic studies proving the safety and effectiveness of GQDs for in vivo applications.

Objectives: This study evaluated the pharmacokinetics of GQDs radiolabeled with 99mTc, administered intravenously, in rodents (Wistar rats) in two conditions: short and long periods, to compare and understand the biological behavior.

Methods: The graphene quantum dots were produced and characterized by RX diffractometry, Raman spectroscopy, and atomic force microscopy. The pharmacokinetic analysis was performed following the radiopharmacokinetics concepts, using radiolabeled graphene quantum dots with technetium 99 metastable (99mTc). The radiolabeling process of the graphene quantum dots with 99mTc was performed by the direct via.

Results: The results indicate that the pharmacokinetic analyses with GQDs over a longer period were more accurate. Following a bicompartmental model, the long-time analysis considers each pharmacokinetic phase of drugs into the body. Furthermore, the data demonstrated that short-time analysis could lead to distortions in pharmacokinetic parameters, leading to misinterpretations.

Conclusion: The evaluation of the pharmacokinetics of GQDs over long periods is more meaningful than the evaluation over short periods.

Keywords: 99mTc labeling; GQDs.; Graphene quantum dots; In vivo analyses; Nanoparticles; Pharmacokinetics.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Maiti D.; Tong X.; Mou X.; Yang K.; Carbon-based nanomaterials for biomedical applications: A recent study. Front Pharmacol 2019,9,1401 - DOI - PubMed
    1. Magne T.M.; de Oliveira Vieira T.; Alencar L.M.R.; Junior F.F.M.; Gemini-Piperni S.; Carneiro S.V.; Fechine L.M.U.D.; Freire R.M.; Golokhvast K.; Metrangolo P.; Fechine P.B.A.; Santos-Oliveira R.; Graphene and its derivatives: Understanding the main chemical and medicinal chemistry roles for biomedical applications. J Nanostructure Chem 2021,1-35 - DOI - PubMed
    1. Novoselov K.S.; Fal’ko V.I.; Colombo L.; Gellert P.R.; Schwab M.G.; Kim K.; A roadmap for graphene. Nature 2012,490(7419),192-200 - DOI - PubMed
    1. Gurunathan S.; Kim J.H.; Synthesis, toxicity, biocompatibility, and biomedical applications of graphene and graphene-related materials. Int J Nanomedicine 2016,11,1927-1945 - DOI - PubMed
    1. Novoselov K.S.; Geim A.K.; Morozov S.V.; Electric field effect in atomically thin carbon films. Science 2004,306(80),666-669

LinkOut - more resources